SCHEMBL5496225

SCHEMBL5496225

CC(C)(C)CCNCc1ccc2[nH]cc(Cc3ccc(C(N)=O)cc3)c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ HTR1A P08908 2/20 0.45
▸ HTR1B P28222 2/20 0.45
▸ HTR2C P28335 2/20 0.45
▸ HTR7 P34969 2/20 0.45
▸ HTR5A P47898 2/20 0.45
▸ HTR6 P50406 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ HTR1D P28221 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ OPRM1 P35372 1/20 0.43
▸ OPRD1 P41143 1/20 0.43
▸ OPRK1 P41145 1/20 0.43
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ SNCA P37840 9/20 0.41
▸ GPR84 Q9NQS5 1/20 0.41
▸ HTR2A P28223 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5499448 0.85 CYP1A2 (0.45) CYP1A2HSD17B10HTR1AHTR1BHTR2C
SCHEMBL5500442 0.84 HTR1D (0.47) CYP1A2HSD17B10HTR1AHTR1BHTR2C
SCHEMBL5498985 0.82 HTR2A (0.60) KMT2AOPRM1OPRD1OPRK1SNCA
SCHEMBL5498300 0.82 MPO (0.53) CYP1A2HSD17B10HTR1AHTR1BHTR2C
SCHEMBL5501366 0.81 HTR1A (0.45) CYP1A2HSD17B10HTR1AHTR1BHTR2C
SCHEMBL5499589 0.81 OPRM1 (0.49) CYP1A2HSD17B10HTR1AHTR1BHTR2C
SCHEMBL5495196 0.80 SNCA (0.58) CYP1A2HSD17B10HTR1AHTR1BHTR2C
SCHEMBL5499185 0.79 SNCA (0.54) CYP1A2HSD17B10HTR1AHTR1BHTR2C
SCHEMBL5493877 0.79 SNCA (0.54) HTR6OPRM1OPRD1OPRK1SNCA
SCHEMBL5498261 0.79 SNCA (0.54) CYP1A2HSD17B10HTR1AHTR1BHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751103-A1 4-(5-(AMINOMETHYL)-INDOLE-1-YLMETHYL)-BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS OPIOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF OBESITY ELI LILLY AND COMPANY (US) 2007-02-14 — — EP claimed
WO-2005090303-A1 4- (5- (AMINOMETHYL) -INDOLE-1-YLMETHYL) -BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS OPIOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF OBESITY ELI LILLY AND COMPANY (US) 2005-09-29 — — WO claimed
EP-1751103-A1 4-(5-(AMINOMETHYL)-INDOLE-1-YLMETHYL)-BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS OPIOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF OBESITY ELI LILLY AND COMPANY (US) 2007-02-14 — — EP disclosed
WO-2005090303-A1 4- (5- (AMINOMETHYL) -INDOLE-1-YLMETHYL) -BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS OPIOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF OBESITY ELI LILLY AND COMPANY (US) 2005-09-29 — — WO disclosed
Send feedback